UTHRUnited Therapeutics Corporation

$24B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.7B+13.6% YoY

Gross Profit

$1.6B92.7% margin

Operating Income

$556M33.0% margin

Net Income

$476M28.2% margin

EPS (Diluted)

$10.06

Cash Flow

Operating Cash Flow

$598M

Free Cash Flow

$477M

Stock-Based Comp.

$139M

Balance Sheet

Total Assets

$5.2B

Total Liabilities

$1.2B

Stockholders' Equity

$4.0B

Cash & Equivalents

$895M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.5B	+13.6%
Gross Profit	$1.6B	$1.4B	+13.7%
Operating Income	$556M	$594M	-6.4%
Net Income	$476M	$515M	-7.6%

UTHR FY 2021 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena